Citizens Financial Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,601
Closed -$375K 401
2023
Q1
$375K Buy
3,601
+254
+8% +$24.6K 0.01% 330
2022
Q4
$297K Hold
3,347
0.01% 337
2022
Q3
$269K Buy
3,347
+209
+7% +$19.7K 0.01% 339
2022
Q2
$301K Sell
3,138
-6
-0.2% -$720 0.01% 347
2022
Q1
$468K Buy
3,144
+6
+0.2% +$838 0.02% 293
2021
Q4
$445K Sell
3,138
-330
-10% -$46.7K 0.01% 306
2021
Q3
$454K Buy
+3,468
New +$454K 0.02% 300
2020
Q1
Sell
-87
Closed -$10K 1130
2019
Q4
$10K Buy
+87
New +$9.27K ﹤0.01% 751

Other funds holding CNMD

Citizens Financial Group's CNMD Position: Q2 2023 in Review

Citizens Financial Group sold out of CONMED (CNMD) in Q2 2023, closing a stake of 3,601 shares — an estimated $375K sold.

Citizens Financial Group first reported a position in CNMD in Q4 2019 and held it in 8 quarters. The position peaked at $468K in Q1 2022. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

  • Citizens Financial Group reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
  • Citizens Financial Group sold 3,601 CONMED shares in Q2 2023, an estimated $375K.
  • Citizens Financial Group first reported a position in CONMED in Q4 2019 and held it in 8 quarters.
  • Citizens Financial Group's CONMED position peaked at $468K in Q1 2022.
  • 263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Citizens Financial Group's 13F filing for Q2 2023, filed 4 Aug 2023.